BioNexus Share Price

BioNexus Share Price

NASDAQ: BGLC | Healthcare
$0.00
-$0.66 (--%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

BioNexus Stock Performance

Open
N/A
Prev. Close
$0.66
Circuit Range
N/A
Day Range
N/A
Year Range
$0.66 - $4.57
Volume
N/A
Average Traded
N/A

BioNexus Share Price Chart

Line chart of the BioNexus price trend over the selected period. The price fell overall, ranging from 0.66 to 0.73, ending at 0.66.
$0.00$0.00
L
Show Current Price
H

BioNexus Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.00
Revenue (TTM)
$7.42B
Return On Equity (TTM)
-38.83%
Profit Margin
-40.16%
Debt to Equity
0.01
Quarterly Earnings Growth YoY
-0.96%

BioNexus Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.48$0.02$0.08$0.05
Net Profit-$1.04-$0.54-$0.29-$1.05
Net Profit Margin-216.67%-2700.00%-362.50%-2100.00%
Income ChangeN/A48.08%46.30%-262.07%

BioNexus Annual Profit & Loss

All figures in USD

Particulars202320242025
Revenue$9.77$9.51$7.42
Net Profit-$2.63-$1.60-$2.98
Net Profit Margin-26.92%-16.82%-40.16%
Income ChangeN/A39.16%-86.25%

BioNexus Balance Sheet

All figures in USD Million

Particulars202520242023
Non Current Assets3.893.03.35
Current Assets5.377.438.05
Total Assets9.2510.4311.4
Non Current Liabilities0.120.160.11
Current Liabilities0.521.951.63
Total Liabilities0.642.111.74
Shareholders' Equity8.618.329.66

BioNexus Cash Flow

Annually

All figures in USD Million

Particulars202520242023
Operating-1.84-2.09-1.82
Investing0.940.42-1.79
Financing0.30.06.27

Corporate Actions

Split
Ex-date: 07 Apr 2025

Split
Ex-date: 20 Jul 2023

About BioNexus

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

BioNexus Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.06
$0.66
-37.74%
Oct 2026
$1.24
$1.06
-22.91%
Sep 2026
$1.40
$1.38
+4.17%
Aug 2026
$1.32
$1.32
-14.29%
Jul 2026
$1.54
$1.54
-21.83%
Jun 2026
$1.85
$1.97
-10.86%
May 2026
$2.13
$2.21
-4.33%
Apr 2026
$2.31
$2.31
-10.47%
Mar 2026
$2.57
$2.58
-4.44%
Feb 2026
$2.64
$2.70
+1.89%
Jan 2026
$3.56
$2.65
-33.25%
Dec 2025
$4.46
$3.97
-10.18%

BioNexus Share Price FAQs